{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
m picosulfate
to a specific field?
Status:
Investigational
Source:
NCT03846453: Phase 3 Interventional Completed Dry Eye
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03858634: Phase 2 Interventional Completed Chronic Idiopathic Urticaria
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00001296: Phase 3 Interventional Completed Melanoma
(1992)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04655586: Phase 2/Phase 3 Interventional Completed Covid19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04612530: Phase 1 Interventional Unknown status Pancreatic Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sampeginterferon beta-1a [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00791570: Phase 1 Interventional Completed Neovascular Maculopathy
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00791570: Phase 1 Interventional Completed Neovascular Maculopathy
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04692181: Phase 1/Phase 2 Interventional Active, not recruiting Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04295538: Phase 2 Interventional Active, not recruiting Spinal Cord Injury (SCI)
(2020)
Source URL:
Class:
PROTEIN
